These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24842910)

  • 41. The Development of Protein Chips for High Throughput Screening (HTS) of Chemically Labeling Small Molecular Drugs.
    Feng Y; Wang B; Chu X; Wang Y; Zhu L
    Mini Rev Med Chem; 2016; 16(10):846-50. PubMed ID: 25963567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular complexity and fragment-based drug discovery: ten years on.
    Leach AR; Hann MM
    Curr Opin Chem Biol; 2011 Aug; 15(4):489-96. PubMed ID: 21665521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gaining confidence in high-throughput screening.
    Bibette J
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):649-50. PubMed ID: 22308304
    [No Abstract]   [Full Text] [Related]  

  • 44. Editorial overview: Next generation therapeutics: Creating and exploiting the chemistry of large numbers.
    Scheuermann J; Neri D
    Curr Opin Chem Biol; 2015 Jun; 26():iv-v. PubMed ID: 25890575
    [No Abstract]   [Full Text] [Related]  

  • 45. Evolution of Novartis' Small Molecule Screening Deck Design.
    Schuffenhauer A; Schneider N; Hintermann S; Auld D; Blank J; Cotesta S; Engeloch C; Fechner N; Gaul C; Giovannoni J; Jansen J; Joslin J; Krastel P; Lounkine E; Manchester J; Monovich LG; Pelliccioli AP; Schwarze M; Shultz MD; Stiefl N; Baeschlin DK
    J Med Chem; 2020 Dec; 63(23):14425-14447. PubMed ID: 33140646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virtual screening of compound libraries.
    Cerqueira NM; Sousa SF; Fernandes PA; Ramos MJ
    Methods Mol Biol; 2009; 572():57-70. PubMed ID: 20694685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solid-phase biological assays for drug discovery.
    Forsberg EM; Sicard C; Brennan JD
    Annu Rev Anal Chem (Palo Alto Calif); 2014; 7():337-59. PubMed ID: 25000820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BIOCHEMISTRY. DNA helps build molecular libraries for drug testing.
    Gura T
    Science; 2015 Dec; 350(6265):1139-40. PubMed ID: 26785450
    [No Abstract]   [Full Text] [Related]  

  • 49. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural basis for inhibition of the Tob-CNOT7 interaction by a fragment screening approach.
    Bai Y; Tashiro S; Nagatoishi S; Suzuki T; Yan D; Liu R; Tsumoto K; Bartlam M; Yamamoto T
    Protein Cell; 2015 Dec; 6(12):924-8. PubMed ID: 26518565
    [No Abstract]   [Full Text] [Related]  

  • 51. Learning from our mistakes: the 'unknown knowns' in fragment screening.
    Davis BJ; Erlanson DA
    Bioorg Med Chem Lett; 2013 May; 23(10):2844-52. PubMed ID: 23562240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Historical overview of chemical library design.
    Dolle RE
    Methods Mol Biol; 2011; 685():3-25. PubMed ID: 20981516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psoromic acid derivatives: a new family of small-molecule pre-mRNA splicing inhibitors discovered by a stage-specific high-throughput in vitro splicing assay.
    Samatov TR; Wolf A; Odenwälder P; Bessonov S; Deraeve C; Bon RS; Waldmann H; Lührmann R
    Chembiochem; 2012 Mar; 13(5):640-4. PubMed ID: 22334518
    [No Abstract]   [Full Text] [Related]  

  • 54. One size does not fit all: Challenging some dogmas and taboos in drug discovery.
    Chai CL; Mátyus P
    Future Med Chem; 2016 Jan; 8(1):29-38. PubMed ID: 26689236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New directions in library design and analysis.
    Gillet VJ
    Curr Opin Chem Biol; 2008 Jun; 12(3):372-8. PubMed ID: 18331851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Target identification and mechanism of action in chemical biology and drug discovery.
    Schenone M; Dančík V; Wagner BK; Clemons PA
    Nat Chem Biol; 2013 Apr; 9(4):232-40. PubMed ID: 23508189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Screening Assay Cascade to Identify and Characterize Novel Selective Estrogen Receptor Downregulators (SERDs).
    Callis R; Rabow A; Tonge M; Bradbury R; Challinor M; Roberts K; Jones K; Walker G
    J Biomol Screen; 2015 Jul; 20(6):748-59. PubMed ID: 25851036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficient hit and lead compound evaluation strategy based on off-rate screening by surface plasmon resonance.
    Liu L
    J Med Chem; 2014 Apr; 57(7):2843-4. PubMed ID: 24654838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fragment screening using X-ray crystallography.
    Davies TG; Tickle IJ
    Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.